Teva Pharmaceutical Industries Limited (TEVA)

NYSE: TEVA · Real-Time Price · USD

36.36

-0.26 (-0.71%)

At close: Sep 4, 2026, 4:00 PM EDT

37.19

+0.83 (2.28%)

After-hours: Sep 4, 2026, 7:59 PM EDT

Teva Pharmaceutical Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	42,370	35,807	25,006	11,703	10,129	8,835
Market Cap Growth	96.99%	43.19%	113.68%	15.54%	14.65%	-16.46%
Enterprise Value	55,609	50,699	41,281	30,334	30,275	31,945
Last Close Price	36.36	31.21	22.04	10.44	9.12	8.01

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	60.43	25.40	-	-	-	21.19
Forward PE	12.96	12.07	8.35	4.21	3.63	3.02
PS Ratio	2.45	2.08	1.51	0.74	0.68	0.56
PB Ratio	5.47	4.52	4.37	1.44	1.18	0.79
P/FCF Ratio	31.46	31.19	33.39	13.90	9.72	37.44
P/OCF Ratio	22.32	21.71	20.05	8.56	6.37	11.07
PEG Ratio	2.16	1.82	6.69	0.40	1.63	0.68

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	3.21	2.94	2.50	1.91	2.03	2.01
EV/EBITDA Ratio	13.03	10.23	9.31	6.99	7.63	7.25
EV/EBIT Ratio	16.95	12.83	12.24	9.52	11.37	10.38
EV/FCF Ratio	41.28	44.16	55.12	36.03	29.06	135.36

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	2.18	2.18	3.18	2.50	2.52	2.10
Debt / EBITDA Ratio	3.84	3.39	3.98	4.53	5.26	5.19
Debt / FCF Ratio	12.54	15.01	24.28	24.08	20.80	99.97
Net Debt / Equity Ratio	1.71	1.73	2.60	2.10	2.19	1.91
Net Debt / EBITDA Ratio	3.10	2.76	3.36	3.93	4.75	4.86
Net Debt / FCF Ratio	9.83	11.91	19.87	20.25	18.11	90.80
Asset Turnover	0.43	0.43	0.40	0.36	0.33	0.32
Inventory Turnover	2.45	2.69	2.41	2.09	2.08	2.02
Quick Ratio	0.46	0.54	0.50	0.54	0.57	0.61
Current Ratio	0.88	1.04	0.98	1.02	1.05	1.14
Return on Equity (ROE)	9.69%	20.79%	-28.30%	-7.36%	-25.19%	4.09%
Return on Assets (ROA)	5.13%	6.17%	5.09%	4.55%	3.63%	3.91%
Return on Invested Capital (ROIC)	15.21%	18.73%	14.74%	12.10%	8.85%	6.18%
Return on Capital Employed (ROCE)	13.50%	14.50%	12.70%	10.20%	8.20%	8.40%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	1.67%	3.94%	-6.55%	-4.78%	-24.15%	4.72%
FCF Yield	3.18%	3.21%	3.00%	7.20%	10.29%	2.67%
Buyback Yield / Dilution	-2.24%	-2.83%	-1.07%	-0.81%	-0.27%	-1.10%
Total Shareholder Return	-2.24%	-2.83%	-1.07%	-0.81%	-0.27%	-1.10%

SEC Filings: 10-K · 10-Q